These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19465153)

  • 21. Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria.
    Starzengruber P; Segagni Lusignani L; Wrba T; Mitteregger D; Indra A; Graninger W; Presterl E; Diab-Elschahawi M
    Wien Klin Wochenschr; 2014 Jul; 126(13-14):427-30. PubMed ID: 24903143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007.
    Fenner L; Frei R; Gregory M; Dangel M; Stranden A; Widmer AF
    Eur J Clin Microbiol Infect Dis; 2008 Dec; 27(12):1201-7. PubMed ID: 18560909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
    Nitzan O; Elias M; Chazan B; Raz R; Saliba W
    World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The A, B, BI, and Cs of Clostridium difficile.
    Dubberke ER
    Clin Infect Dis; 2009 Oct; 49(8):1148-52. PubMed ID: 19780660
    [No Abstract]   [Full Text] [Related]  

  • 25. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.
    Kuntz JL; Chrischilles EA; Pendergast JF; Herwaldt LA; Polgreen PM
    BMC Infect Dis; 2011 Jul; 11():194. PubMed ID: 21762504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
    Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypervirulent Clostridium difficile strains in hospitalized patients, Canada.
    Mulvey MR; Boyd DA; Gravel D; Hutchinson J; Kelly S; McGeer A; Moore D; Simor A; Suh KN; Taylor G; Weese JS; Miller M;
    Emerg Infect Dis; 2010 Apr; 16(4):678-81. PubMed ID: 20350386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ICU-Onset Clostridium difficile infection in a university hospital in China: a prospective cohort study.
    Wang X; Cai L; Yu R; Huang W; Zong Z
    PLoS One; 2014; 9(11):e111735. PubMed ID: 25372033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital.
    Belmares J; Johnson S; Parada JP; Olson MM; Clabots CR; Bettin KM; Peterson LR; Gerding DN
    Clin Infect Dis; 2009 Oct; 49(8):1141-7. PubMed ID: 19780659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities.
    Archbald-Pannone LR; Boone JH; Carman RJ; Lyerly DM; Guerrant RL
    J Hosp Infect; 2014 Dec; 88(4):218-21. PubMed ID: 25228227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype.
    Fawley WN; Wilcox MH;
    J Clin Microbiol; 2011 Dec; 49(12):4333-7. PubMed ID: 21956986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism.
    Klaassen CH; van Haren HA; Horrevorts AM
    J Clin Microbiol; 2002 Jan; 40(1):101-4. PubMed ID: 11773100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.
    Muto CA; Blank MK; Marsh JW; Vergis EN; O'Leary MM; Shutt KA; Pasculle AW; Pokrywka M; Garcia JG; Posey K; Roberts TL; Potoski BA; Blank GE; Simmons RL; Veldkamp P; Harrison LH; Paterson DL
    Clin Infect Dis; 2007 Nov; 45(10):1266-73. PubMed ID: 17968819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients.
    Iwashima Y; Nakamura A; Kato H; Kato H; Wakimoto Y; Wakiyama N; Kaji C; Ueda R
    J Infect Chemother; 2010 Oct; 16(5):329-33. PubMed ID: 20449624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile Infection Among US Emergency Department Patients With Diarrhea and No Vomiting.
    Abrahamian FM; Talan DA; Krishnadasan A; Citron DM; Paulick AL; Anderson LJ; Goldstein EJC; Moran GJ;
    Ann Emerg Med; 2017 Jul; 70(1):19-27.e4. PubMed ID: 28242058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C. difficile infection (CDI) in a long-term acute care facility (LTAC).
    Goldstein EJ; Polonsky J; Touzani M; Citron DM
    Anaerobe; 2009 Dec; 15(6):241-3. PubMed ID: 19683064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.
    Barbut F; Gariazzo B; Bonné L; Lalande V; Burghoffer B; Luiuz R; Petit JC
    Infect Control Hosp Epidemiol; 2007 Feb; 28(2):131-9. PubMed ID: 17265393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulsed-field gel electrophoresis can yield DNA fingerprints of degradation-susceptible Clostridium difficile strains.
    Fawley WN; Wilcox MH
    J Clin Microbiol; 2002 Sep; 40(9):3546-7; author reply 3547. PubMed ID: 12202619
    [No Abstract]   [Full Text] [Related]  

  • 39. Recognition of Clostridium difficile PCR-ribotypes 001, 027 and 126/078 using an extended MALDI-TOF MS system.
    Reil M; Erhard M; Kuijper EJ; Kist M; Zaiss H; Witte W; Gruber H; Borgmann S
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1431-6. PubMed ID: 21503840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.
    Kallen AJ; Thompson A; Ristaino P; Chapman L; Nicholson A; Sim BT; Lessa F; Sharapov U; Fadden E; Boehler R; Gould C; Limbago B; Blythe D; McDonald LC
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):264-72. PubMed ID: 19215193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.